NICEdrug.ch, a workflow for rational drug design and systems-level analysis of drug metabolism
The discovery of a drug requires over a decade of intensive research and financial investments – and still has a high risk of failure. To reduce this burden, we developed the NICEdrug.ch resource, which incorporates 250,000 bioactive molecules, and studied their enzymatic metabolic targets, fate, an...
Main Authors: | Homa MohammadiPeyhani, Anush Chiappino-Pepe, Kiandokht Haddadi, Jasmin Hafner, Noushin Hadadi, Vassily Hatzimanikatis |
---|---|
Format: | Article |
Language: | English |
Published: |
eLife Sciences Publications Ltd
2021-08-01
|
Series: | eLife |
Subjects: | |
Online Access: | https://elifesciences.org/articles/65543 |
Similar Items
-
A computational workflow for the expansion of heterologous biosynthetic pathways to natural product derivatives
by: Jasmin Hafner, et al.
Published: (2021-03-01) -
Current insights toward kidney injury: Decrypting the dual role and mechanism involved of herbal drugs in inducing kidney injury and its treatment
by: T.P. Sri Laasya, et al.
Published: (2020-11-01) -
Food Bioactive Compounds and Their Interference in Drug Pharmacokinetic/Pharmacodynamic Profiles
by: Matteo Briguglio, et al.
Published: (2018-12-01) -
Nanotechnological approach to delivering nutraceuticals as promising drug candidates for the treatment of atherosclerosis
by: Sindhu C. Pillai, et al.
Published: (2021-01-01) -
Data-driven prediction of adverse drug reactions induced by drug-drug interactions
by: Ruifeng Liu, et al.
Published: (2017-06-01)